IMMUNOTHERAPY TARGETING STROMAL CD5L IN OVARIAN CANCER

$720,001FY2020Defense Health AgencyDOD

The Univeristy Of Texas M.D. Anderson Cancer Center

Investigators

View source on USAspending →